Security key
492327101
Keros Therapeutics, Inc. - Common Stock, $0.0001 par value per share (KROS)
CUSIP: 492327101
Q2 2021 13F Holders as of 30 Jun 2021
- Type / Class
- Equity / Common Stock, $0.0001 par value per share
- Shares outstanding
- 19,716,217
- Total 13F shares
- 14,120,390
- Share change
- -291,690
- Total reported value
- $599,680,759
- Price per share
- $42.47
- Number of holders
- 79
- Value change
- -$43,588,395
- Number of buys
- 51
- Number of sells
- 33
Report period
Q2 2021
Institutions
79
Top holders
10
KROS full security history
Newer quarter: Q3 2021
Previous quarter: Q1 2021
Keros Therapeutics, Inc. SEC filings
Keros Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 492327101
Recent filing periods:
Top shareholders of KROS - Keros Therapeutics, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FMR LLC |
13F
|
Company |
15%
|
2,928,117
|
$180,226,000 | — | 31 Mar 2021 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
8.5%
|
1,679,417
|
$103,368,000 | — | 31 Mar 2021 | |
| Foresite Capital Management IV, LLC |
13F
|
Company |
7%
|
1,382,641
|
$85,102,000 | — | 31 Mar 2021 | |
| BlackRock Finance, Inc. |
13F
|
Company |
6.2%
|
1,224,045
|
$75,339,000 | — | 31 Mar 2021 | |
| Consonance Capital Management LP |
13F
|
Company |
4.5%
|
890,209
|
$54,792,000 | — | 31 Mar 2021 | |
| STATE STREET CORP |
13F
|
Company |
3.7%
|
723,823
|
$44,551,000 | — | 31 Mar 2021 | |
| VANGUARD GROUP INC |
13F
|
Company |
3.1%
|
602,646
|
$37,092,000 | — | 31 Mar 2021 | |
| ALKEON CAPITAL MANAGEMENT LLC |
13F
|
Company |
2.7%
|
523,439
|
$32,218,000 | — | 31 Mar 2021 | |
| Nantahala Capital Management, LLC |
13F
|
Company |
2.3%
|
460,372
|
$28,336,000 | — | 31 Mar 2021 | |
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
|
Company |
2.2%
|
427,414
|
$26,307,000 | — | 31 Mar 2021 | |
| CHI Advisors LLC |
13F
|
Company |
2%
|
400,468
|
$24,649,000 | — | 31 Mar 2021 | |
| VR Adviser, LLC |
13F
|
Company |
1.9%
|
372,306
|
$22,915,000 | — | 31 Mar 2021 | |
| Clal Insurance Enterprises Holdings Ltd |
13F
|
Company |
1.6%
|
320,000
|
$19,696,000 | — | 31 Mar 2021 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
1.3%
|
260,179
|
$16,014,000 | — | 31 Mar 2021 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
1.1%
|
223,162
|
$13,736,000 | — | 31 Mar 2021 | |
| Invesco Ltd. |
13F
|
Company |
0.97%
|
191,423
|
$11,783,000 | — | 31 Mar 2021 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.88%
|
174,021
|
$10,710,000 | — | 31 Mar 2021 | |
| Opaleye Management Inc. |
13F
|
Company |
0.8%
|
157,500
|
$9,694,000 | — | 31 Mar 2021 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.66%
|
130,265
|
$8,018,000 | — | 31 Mar 2021 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.65%
|
127,925
|
$7,873,000 | — | 31 Mar 2021 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.65%
|
127,870
|
$7,871,000 | — | 31 Mar 2021 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.63%
|
124,287
|
$7,650,000 | — | 31 Mar 2021 | |
| Fairmount Funds Management LLC |
13F
|
Company |
0.55%
|
109,333
|
$6,729,000 | — | 31 Mar 2021 | |
| Marshall Wace North America L.P. |
13F
|
Company |
0.55%
|
108,059
|
$6,651,000 | — | 31 Mar 2021 | |
| Darwin Global Management, Ltd. |
13F
|
Company |
0.44%
|
86,887
|
$5,348,000 | — | 31 Mar 2021 | |
| KENNEDY CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.34%
|
67,980
|
$4,184,000 | — | 31 Mar 2021 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.3%
|
58,310
|
$3,589,000 | — | 31 Mar 2021 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.22%
|
42,729
|
$2,630,000 | — | 31 Mar 2021 | |
| CITIGROUP INC |
13F
|
Company |
0.22%
|
42,697
|
$2,628,000 | — | 31 Mar 2021 | |
| Rafferty Asset Management, LLC |
13F
|
Company |
0.17%
|
34,031
|
$2,095,000 | — | 31 Mar 2021 | |
| Atom Investors LP |
13F
|
Company |
0.14%
|
27,885
|
$1,716,000 | — | 31 Mar 2021 | |
| Eversept Partners, LP |
13F
|
Company |
0.14%
|
27,631
|
$1,700,688 | — | 31 Mar 2021 | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM |
13F
|
Company |
0.13%
|
26,373
|
$1,623,000 | — | 31 Mar 2021 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.13%
|
26,142
|
$1,609,000 | — | 31 Mar 2021 | |
| Altshuler Shaham Ltd |
13F
|
Company |
0.11%
|
22,516
|
$1,386,000 | — | 31 Mar 2021 | |
| Swiss National Bank |
13F
|
Company |
0.1%
|
20,600
|
$1,268,000 | — | 31 Mar 2021 | |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM |
13F
|
Company |
0.1%
|
19,931
|
$1,227,000 | — | 31 Mar 2021 | |
| STATE OF WISCONSIN INVESTMENT BOARD |
13F
|
Company |
0.09%
|
17,900
|
$1,102,000 | — | 31 Mar 2021 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.09%
|
17,046
|
$1,049,000 | — | 31 Mar 2021 | |
| UBS Group AG |
13F
|
Company |
0.08%
|
15,567
|
$958,000 | — | 31 Mar 2021 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.07%
|
14,487
|
$892,000 | — | 31 Mar 2021 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.07%
|
13,675
|
$842,000 | — | 31 Mar 2021 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.07%
|
13,600
|
$837,000 | — | 31 Mar 2021 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.06%
|
11,900
|
$732,000 | — | 31 Mar 2021 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.05%
|
9,652
|
$593,000 | — | 31 Mar 2021 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.04%
|
8,478
|
$522,000 | — | 31 Mar 2021 | |
| AMERICAN INTERNATIONAL GROUP, INC. |
13F
|
Company |
0.04%
|
7,731
|
$476,000 | — | 31 Mar 2021 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
0.04%
|
7,579
|
$466,000 | — | 31 Mar 2021 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.04%
|
7,000
|
$430,850 | — | 31 Mar 2021 | |
| ProShare Advisors LLC |
13F
|
Company |
0.03%
|
6,755
|
$416,000 | — | 31 Mar 2021 |
Institutional Holders of Keros Therapeutics, Inc. - Common Stock, $0.0001 par value per share (KROS) as of Q2 2021
As of 30 Jun 2021,
Keros Therapeutics, Inc. - Common Stock, $0.0001 par value per share (KROS) was held by
79 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
14,120,390 shares.
The largest 10 holders included
FMR LLC, ORBIMED ADVISORS LLC, BlackRock Inc., Consonance Capital Management LP, ALKEON CAPITAL MANAGEMENT LLC, STATE STREET CORP, VANGUARD GROUP INC, Nantahala Capital Management, LLC, EVENTIDE ASSET MANAGEMENT, LLC, and Point72 Asset Management, L.P..
This page lists
79
institutional shareholders reporting positions in this security
for the Q2 2021 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2021 vs Q1 2021 Across Filers
Q1 2021 holders
83
Q2 2021 holders
79
Holder diff
-4
| Investor | Q1 2021 Shares | Q2 2021 Shares | Share Diff | Share Chg % | Q1 2021 Value $ | Q2 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.